The device, called the Abbott Gallant, is a biventricular implantable cardiac defibrillator that earned FDA approval in July and is the first to wirelessly pair with a smartphone app for patients.
Mohamad Sinno, MD, a cardiac electrophysiology specialist at St. Elizabeth Edgewood, led the procedure.
Learn more here.
More articles on cardiology:
Potential COVID-19 treatment could increase cardiac event risk if taken with certain drugs
NewYork-Presbyterian Brooklyn Methodist Hospital names new cardiology chief
Journal of Invasive Cardiology to go 100% digital
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
